Rockwell Medical Inc
NASDAQ:RMTI

Watchlist Manager
Rockwell Medical Inc Logo
Rockwell Medical Inc
NASDAQ:RMTI
Watchlist
Price: 1.16 USD 0.87% Market Closed
Market Cap: $45.7m

Operating Margin

-5.7%
Current
Improving
by 1.4%
vs 3-y average of -7.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-5.7%
=
Operating Income
$-4.3m
/
Revenue
$75.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-5.7%
=
Operating Income
$-4.3m
/
Revenue
$75.6m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Rockwell Medical Inc
NASDAQ:RMTI
45.7m USD
Loading...
JP
Hoya Corp
TSE:7741
8.6T JPY
Loading...
CH
Alcon AG
SIX:ALC
30.4B CHF
Loading...
US
Medline Inc
NASDAQ:MDLN
35.8B USD
Loading...
DK
Coloplast A/S
CSE:COLO B
119.1B DKK
Loading...
US
Align Technology Inc
NASDAQ:ALGN
11.9B USD
Loading...
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP
Loading...
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY
Loading...
KR
HLB Inc
KOSDAQ:028300
8.7T KRW
Loading...
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD
Loading...
CH
Ypsomed Holding AG
SIX:YPSN
4.3B CHF
Loading...

Market Distribution

Lower than 70% of companies in the United States of America
Percentile
30th
Based on 14 112 companies
30th percentile
-5.7%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Rockwell Medical Inc
Glance View

Market Cap
45.7m USD
Industry
Health Care

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. The company is headquartered in Wixom, Michigan and currently employs 300 full-time employees. The firm is developing and commercializing its technology platform, Ferric Pyrophosphate Citrate (FPC) for the transformative treatments for iron deficiency in multiple disease states. The company is also a supplier of hemodialysis concentrate products to kidney dialysis clinics. The firm has developed therapies namely Triferic and Triferic AVNU from its FPC platform. The Company’s products from its FPC platform, Triferic (dialysate) and Triferic AVNU intravenous (IV), is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients. Its Triferic AVNU, is an IV formulation of Triferic, for use by hemodialysis patients. its dialysis concentrates products include CitraPure Citric Acid Concentrate, Dri-Sate Dry Acid Concentrate, RenalPure Liquid Acid Concentrate, Dry Acid Concentrate Mixer, RenalPure and SteriLyte Bicarbonate Concentrate and Ancillary products.

RMTI Intrinsic Value
1.1 USD
Overvaluation 5%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-5.7%
=
Operating Income
$-4.3m
/
Revenue
$75.6m
What is Rockwell Medical Inc's current Operating Margin?

The current Operating Margin for Rockwell Medical Inc is -5.7%, which is above its 3-year median of -7.1%.

How has Operating Margin changed over time?

Over the last 3 years, Rockwell Medical Inc’s Operating Margin has increased from -33.7% to -5.7%. During this period, it reached a low of -33.7% on Sep 30, 2022 and a high of 0.6% on Dec 31, 2024.

Back to Top